Lipids
Enzymatic Esterase--Oxidase, Cholesterol. 510(k) K251091, from Truvian Health (San Diego, CA). Product code CHH, class 1.
As of Nov 18, 2026, K251091 is an FDA 510(k) held by Truvian Health, substantially equivalent on Dec 30, 2025 after 264 days, with no recalls tied to it in FDA's recall database.
- Review time: 264 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFLipids is part of the TruWellness Panelâ„¢ and is intended for use on the TruVerusâ„¢. Lipids (part of the TruWellness Panelâ„¢) is an in vitro diagnostic device and intended to be used for the quantitative determination of Total Cholesterol (TChol) and Triglycerides (TRIG) in lithium-heparinized venous whole blood in clinical laboratory or point-of-care settings.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Piccolo Total Cholesterol Test SystemK023642 · Abaxis, Inc. · Jan 24, 2003
- Piccolo Triglycerides Test SystemK023639 · Abaxis, Inc. · Jan 24, 2003
- Comprehensive Metabolic Panel, skyla Clinical Chemistry Analyzer, Minicare C300 Clinical Chemistry AnalyzerK171971 · Lite-On Technology Corp. H.S.P.B. · Jan 25, 2018
- Piccolo(Tm)K942782 · Abaxis, Inc. · Mar 13, 1995
Other CHH clearances
The newest 510(k)s for the same product code; see every CHH device- CHOLESTEROL; HDL-cholesterol ; LDL-cholesterol; TRIGLYCERIDESK232404 · Medicon Hellas S.A · Aug 9, 2024
- Cholesterol2K203597 · Abbott Ireland Diagnostics Division · Jun 30, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 10, 2025
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1175
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files